Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 30

The DOI matches its Crossref record.

Silk-elastinlike protein polymers enhance the efficacy of a therapeutic glycosaminoglycan for prophylactic treatment of radiation-induced proctitis

Jensen, Mark Martin, Jia, Wanjian, Isaacson, Kyle J., Schults, Austin, Cappello, Joseph, Prestwich, Glenn D., Oottamasathien, Siam, Ghandehari, Hamidreza · 2017 · Journal of Controlled Release

Abstract

ABSTRACT Radiation‐induced proctitis (RIP) is the most common clinical adverse effect for patients receiving radiotherapy as part of the standard course of treatment for ovarian, prostate, colon, and bladder cancers. RIP limits radiation dosage, interrupts treatment, and lowers patients' quality of life. A prophylactic treatment that protects the gastrointestinal tract from deleterious effects of radiotherapy will significantly improve patient quality of life and may allow for higher and more regular doses of radiation therapy. Semi‐synthetic glycosaminoglycan (GAG), generated from the sulfation of hyaluronic acid, are anti‐inflammatory but have difficulty achieving therapeutic levels in many tissues. To enhance the delivery of GAG, we created an in situ gelling rectal delivery system using silk‐elastinlike protein polymers (SELPs). Using solutions of SELP 815K (which contains 6 repeats of blocks comprised of 8 silk‐like units, 15 elastin‐like units, and 1 lysine‐substituted elastin‐like unit) with GAG GM‐0111, we created an injectable delivery platform that transitioned in < 5 min from a liquid at room temperature to a hydrogel at body temperature. The hydrogels released 50% of their payload within 30 min and enhanced the accumulation of GAG in the rectum compared to traditional enema‐based delivery. Using a murine model of radiation‐induced proctitis, the prophylactic delivery of a single dose of GAG from a SELP matrix administered prior to irradiation significantly reduced radiation‐induced pain after 3, 7, and 21 days by 53 ± 4%, 47 ± 10%, and 12 ± 6%, respectively. Matrix‐mediated delivery of GAG by SELP represents an innovative method for more effective treatment of RIP and promises to improve quality of life of cancer patients by allowing higher radiotherapy doses with improved safety. Graphical abstract Figure. No Caption available.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2017.02.025

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 67

  1. Hauer-Jensen, 2007, Radiation damage to the gastrointestinal tract: mechanisms, diagnosis, and management, Curr. Opin. Support. Palliat. Care, 1, 23, 10.1097/SPC.0b013e3281108014 · DOI
  2. Hauer-Jensen, 2003, Bowel injury: current and evolving management strategies, Semin. Radiat. Oncol., 13, 357
  3. Bansal, 2016, Exploring the management of radiation proctitis in current clinical practice, J. Clin. Diagn. Res., 10
  4. Hille, 2005, A phase {III} randomized, placebo-controlled, double-blind study of misoprostol rectal suppositories to prevent acute radiation proctitis in patients with prostate cancer, Int. J. Radiat. Oncol. Biol. Phys., 63, 1488, 10.1016/j.ijrobp.2005.05.063 · doi:10.1016/j.ijrobp.2005.05.063
  5. Waddell, 1999, Prevention of chronic radiation enteritis, J. Am. Coll. Surg., 189, 611, 10.1016/S1072-7515(99)00199-4 · DOI
  6. Wortel, 2016, Late side effects after image guided intensity modulated radiation therapy compared to 3d-conformal radiation therapy for prostate cancer: results from 2 prospective cohorts, Int. J. Radiat. Oncol. Biol. Phys., 95, 680, 10.1016/j.ijrobp.2016.01.031 · doi:10.1016/j.ijrobp.2016.01.031
  7. Wortel, 2015, Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients, Int. J. Radiat. Oncol. Biol. Phys., 91, 737, 10.1016/j.ijrobp.2014.12.017 · doi:10.1016/j.ijrobp.2014.12.017
  8. Muldermans, 2016, Stereotactic body radiation therapy for oligometastatic prostate cancer, Int. J. Radiat. Oncol. Biol. Phys., 95, 696, 10.1016/j.ijrobp.2016.01.032 · doi:10.1016/j.ijrobp.2016.01.032
  9. Shrader-Bogen, 1997, Quality of life and treatment outcomes, Cancer, 79, 1977, 10.1002/(SICI)1097-0142(19970515)79:10<1977::AID-CNCR20>3.0.CO;2-R · DOI · Paper page
  10. Eifel, 1995, Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix, Int. J. Radiat. Oncol. Biol. Phys., 32, 1289, 10.1016/0360-3016(95)00118-I · DOI · Paper page
  11. Shadad, 2013, Gastrointestinal radiation injury: symptoms, risk factors and mechanisms, World J. Gastroenterol., 19, 185, 10.3748/wjg.v19.i2.185 · DOI · Paper page
  12. Widmark, 1994, Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population, Cancer, 74, 2520, 10.1002/1097-0142(19941101)74:9<2520::AID-CNCR2820740921>3.0.CO;2-Q · DOI
  13. Dearnaley, 2007, Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial, Lancet Oncol., 8, 475, 10.1016/S1470-2045(07)70143-2 · DOI · Paper page
  14. Kuban, 2008, Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer, Int. J. Radiat. Oncol. Biol. Phys., 70, 67, 10.1016/j.ijrobp.2007.06.054 · DOI · Paper page
  15. Zelefsky, 2008, Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes, Int. J. Radiat. Oncol. Biol. Phys., 71, 1028, 10.1016/j.ijrobp.2007.11.066 · DOI · Paper page
  16. Kochar, 1991, Radiation induced proctosigmoiditis: prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate, Dig. Dis. Sci., 36, 103
  17. Baum, 1989, Failure of 5-aminosalicylic acid enemas to improve chronic radiation proctitis, Dig. Dis. Sci., 34, 758, 10.1007/BF01540349 · DOI
  18. Talley, 1997, Short-chain fatty acids in the treatment of radiation proctitis, Dis. Colon Rectum, 40, 1046, 10.1007/BF02050927 · DOI
  19. Hille, 2008, Sodium butyrate enemas in the treatment of acute radiation-induced proctitis in patients with prostate cancer and the impact on late proctitis, Strahlentherapie Und Onkol., 184, 686, 10.1007/s00066-008-1896-1 · DOI
  20. Szepesi, 1990, Treatment of radiogenic colitis with a rectal foam containing cortisol. Clinical and pharmacologic data, Strahlentherapie Und Onkol. Organ Der Dtsch. Rontgengesellschaft, 166, 271
  21. Kennedy, 2001, Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C, Am. J. Gastroenterol., 96, 1080, 10.1111/j.1572-0241.2001.03742.x · doi:10.1111/j.1572-0241.2001.03742.x
  22. Ramirez, 1996, Successful endoscopic hemostasis of bleeding colonic diverticula with epinephrine injection, Gastrointest. Endosc., 43, 167, 10.1016/S0016-5107(06)80126-4 · doi:10.1016/s0016-5107(06)80126-4
  23. Stefanelli, 2012, Can we decrease the acute proctitis in prostate cancer patients using hyaluronic acid during radiation therapy: a prospective historically controlled clinical study, Eur. Rev. Med. Pharmacol. Sci., 16, 639
  24. Ramakrishnaiah, 2016, Chronic haemorrhagic radiation proctitis: a review, World J. Gastrointest. Surg., 8, 483, 10.4240/wjgs.v8.i7.483 · doi:10.4240/wjgs.v8.i7.483
  25. Zhou, 2009, Effective treatment of chronic radiation proctitis using radiofrequency ablation, Therap. Adv. Gastroenterol., 2, 149, 10.1177/1756283X08103341 · doi:10.1177/1756283x08103341
  26. Ventrucci, 2001, Efficacy and safety of Nd. YAG laser for the treatment of bleeding from radiation proctocolitis, Dig. Liver Dis., 33, 230, 10.1016/S1590-8658(01)80712-X · doi:10.1016/s1590-8658(01)80712-x
  27. Taylor, 1993, Argon laser therapy for hemorrhagic radiation proctitis: long-term results, Gastrointest. Endosc., 39, 641, 10.1016/S0016-5107(93)70215-1 · DOI
  28. Jensen, 1997, A randomized prospective study of endoscopic bipolar electrocoagulation and heater probe treatment of chronic rectal bleeding from radiation telangiectasia, Gastrointest. Endosc., 45, 20, 10.1016/S0016-5107(97)70298-0 · doi:10.1016/s0016-5107(97)70298-0
  29. Bloomfeld, 2001, Endoscopic therapy of acute diverticular hemorrhage, Am. J. Gastroenterol., 96, 2367, 10.1111/j.1572-0241.2001.04048.x · doi:10.1111/j.1572-0241.2001.04048.x
  30. Sebastian, 2004, Argon plasma coagulation as first-line treatment for chronic radiation proctopathy, J. Gastroenterol. Hepatol., 19, 1169, 10.1111/j.1440-1746.2004.03448.x · doi:10.1111/j.1440-1746.2004.03448.x
  31. Lenz, 2016, Chronic radiation proctopathy: a practical review of endoscopic treatment, World J. Gastrointest. Surg., 8, 151, 10.4240/wjgs.v8.i2.151 · doi:10.4240/wjgs.v8.i2.151
  32. Rotondano, 2003, Long-term outcome of argon plasma coagulation therapy for bleeding caused by chronic radiation proctopathy, Dig. Liver Dis., 35, 806, 10.1016/S1590-8658(03)00454-7 · doi:10.1016/s1590-8658(03)00454-7
  33. Lee, 2013, Prevention of anti-microbial peptide LL-37-induced apoptosis and ATP release in the urinary bladder by a modified glycosaminoglycan, PLoS One, 8, e77854, 10.1371/journal.pone.0077854 · DOI
  34. Pulsipher, 2016, Prevention of sinonasal inflammation by a synthetic glycosaminoglycan, Int. Forum Allergy Rhinol., 1
  35. Oottamasathien, 2013, Physiological relevance of LL-37 induced bladder inflammation and mast cells, J. Urol., 190, 1596, 10.1016/j.juro.2013.01.002 · DOI
  36. Symon, 2010, A murine model for the study of molecular pathogenesis of radiation proctitis, Int. J. Radiat. Oncol. Biol. Phys., 76, 242, 10.1016/j.ijrobp.2009.07.1736 · doi:10.1016/j.ijrobp.2009.07.1736
  37. Lucas, 1956, Amino-acid sequence in a fraction of bombyx silk fibroin, Nature, 178, 861, 10.1038/178861a0 · DOI
  38. Sandberg, 1981, Elastin structure, biosynthesis, and relation to disease states, N. Engl. J. Med., 304, 566, 10.1056/NEJM198103053041004 · DOI · Paper page
  39. Dinerman, 2010, Influence of solute charge and hydrophobicity on partitioning and diffusion in a genetically engineered silk-elastin-like protein polymer hydrogel, Macromol. Biosci., 10, 1235, 10.1002/mabi.201000061 · doi:10.1002/mabi.201000061
  40. Price, 2014, Effect of shear on physicochemical properties of matrix metalloproteinase responsive silk-elastinlike hydrogels, J. Control. Release, 195, 92, 10.1016/j.jconrel.2014.07.044 · DOI
  41. Teng, 2011, Physical crosslinking modulates sustained drug release from recombinant silk-elastinlike protein polymer for ophthalmic applications, J. Control. Release, 156, 186, 10.1016/j.jconrel.2011.07.036 · DOI
  42. Frandsen, 2012, Recombinant protein-based polymers for advanced drug delivery, Chem. Soc. Rev., 41, 2696, 10.1039/c2cs15303c · DOI
  43. Megeed, 2004, Thermal analysis of water in silk-elastin like hydrogels by differential scanning calorimetry, Biomacromolecules, 5, 793, 10.1021/bm0343491 · doi:10.1021/bm0343491
  44. Poursaid, 2016, Silk-elastinlike protein polymer liquid chemoembolic for localized release of doxorubicin and sorafenib, Mol. Pharm., 13, 2736, 10.1021/acs.molpharmaceut.6b00325 · DOI · Paper page
  45. Zhang, 2011, Novel sulfated polysaccharides disrupt cathelicidins, inhibit rage and reduce cutaneous inflammation in a mouse model of rosacea, PLoS One, 6
  46. Rudick, 2009, Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis, BMC Urol., 9, 1, 10.1186/1471-2490-9-16 · DOI
  47. Ren, 1999, Inflammatory models of pain and hyperalgesia, ILAR J., 40, 111, 10.1093/ilar.40.3.111 · DOI · Paper page
  48. The Royal College of Radiologists, 2006, Radiotherapy dose-fractionation, R. Coll. Radiol., 48, 960
  49. Stacey, 2014, Radiation-induced small bowel disease: latest developments and clinical guidance, Ther. Adv. Chronic Dis., 5, 15, 10.1177/2040622313510730 · DOI · Paper page
  50. Oottamasathien, 2011, A murine model of inflammatory bladder disease: cathelicidin peptide induced bladder inflammation and treatment with sulfated polysaccharides, J. Urol., 186, 1684, 10.1016/j.juro.2011.03.099 · DOI
  51. Elia, 2011, Silk-hyaluronan-based composite hydrogels: a novel, securable vehicle for drug delivery, J. Biomater. Appl., 27, 749, 10.1177/0885328211424516 · DOI
  52. Liu, 2004, Disulfide-crosslinked hyaluronan-gelatin sponge: growth of fibrous tissue in vivo, J. Biomed. Mater. Res. A, 68, 142, 10.1002/jbm.a.10142 · DOI
  53. Kirker, 2004, Glycosaminoglycan hydrogels as supplemental wound dressings for donor sites, J. Burn Care Res., 25
  54. Price, 2014, Controlled release from recombinant polymers, J. Control. Release, 190, 304, 10.1016/j.jconrel.2014.06.016 · DOI
  55. Price, 2012, Comparison of silk-elastinlike protein polymer hydrogel and poloxamer in matrix-mediated gene delivery, Int. J. Pharm., 427, 97, 10.1016/j.ijpharm.2011.09.037 · DOI
  56. Poursaid, 2016, Polymeric materials for embolic and chemoembolic applications, J. Control. Release Soc., 240, 414, 10.1016/j.jconrel.2016.02.033 · DOI
  57. Poursaid, 2015, In situ gelling silk-elastinlike protein polymer for transarterial chemoembolization, Biomaterials, 57, 142, 10.1016/j.biomaterials.2015.04.015 · DOI · Paper page
  58. Dinerman, 2002, Solute diffusion in genetically engineered silk – elastinlike protein polymer hydrogels, J. Control. Release, 82, 277, 10.1016/S0168-3659(02)00134-7 · doi:10.1016/s0168-3659(02)00134-7
  59. Megeed, 2002, Controlled release of plasmid DNA from a genetically engineered, Pharm. Res., 19, 954, 10.1023/A:1016406120288 · DOI
  60. Megeed, 2002, Genetically engineered silk-elastinlike protein polymers for controlled drug delivery, Adv. Drug Deliv. Rev., 54, 1075, 10.1016/S0169-409X(02)00063-7 · DOI · Paper page
  61. Cittadini, 2001, Magnesium ions and barium coating of colonic mucosa: is it a simple question of viscosity?, Eur. Radiol., 11, 1429, 10.1007/s003300000782 · doi:10.1007/s003300000782
  62. Cittadini, 1999, Do magnesium ions influence barium mucosal coating of the large bowel?, Eur. Radiol., 9, 1135, 10.1007/s003300050807 · doi:10.1007/s003300050807
  63. Wignarajah, 2006, Simulated human feces for testing human waste processing technologies in space systems, SAE transations, J. Aerosp., 115
  64. Ingram, 2005, Comparative study of enema retention and preference in ulcerative colitis, Postgrad. Med. J., 81, 594, 10.1136/pgmj.2004.031690 · DOI
  65. Otten, 1997, Colonic range of 5-ASA enemas in healthy individuals, with a comparison of their physical and chemical characteristics. An open, single-dose, randomized, cross-over study, Aliment. Pharmacol. Ther., 11, 693, 10.1046/j.1365-2036.1997.00199.x · doi:10.1046/j.1365-2036.1997.00199.x
  66. Laird, 2001, A new model of visceral pain and referred hyperalgesia in the mouse, Pain, 92, 335, 10.1016/S0304-3959(01)00275-5 · DOI · Paper page
  67. Kang, 1999, Rat model for radiation induced proctitis, Eur. J. Cancer, 35, S187, 10.1016/S0959-8049(99)81146-0 · doi:10.1016/s0959-8049(99)81146-0

Cited by

See all 30

Metadata

Authors
Jensen, M. M., Jia, W., Isaacson, K. J., Schults, A., Cappello, J., Prestwich, G. D., Oottamasathien, S., & Ghandehari, H.
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2017-10
Volume
263
Pages
46-56
ISSN
0168-3659
Cited by
30
References
0
Language
en
Funders
  • Huntsman Cancer Institute (P30 CA042014)
  • National Institutes of Health (R01CA107621)
  • University of Utah
  • National Science Foundation (1256065)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Silk-elastinlike protein polymers enhance the efficacy of a therapeutic glycosaminoglycan for prophylactic treatment of radiation-induced proctitis. https://app.cochat.ai/papers/10.1016/j.jconrel.2017.02.025
The paper
Jensen, M. M., Jia, W., Isaacson, K. J., Schults, A., Cappello, J., Prestwich, G. D., Oottamasathien, S., & Ghandehari, H. (2017). Silk-elastinlike protein polymers enhance the efficacy of a therapeutic glycosaminoglycan for prophylactic treatment of radiation-induced proctitis. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2017.02.025

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.